BridgeMD
New treatment option for Cardio Vascular Disease
Official title Norwegian Mental Illness Heart Health Study
ClinicalTrials.gov ID: NCT07085923
What this study is testing
- What it's testing
- Norwegian patients with severe mental illnesses (SMI), such as schizophrenia spectrum or bipolar disorder, lose on average 10 years of life compared to mentally healthy individuals. Much of this gap is due to heart disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Diagnosis of F20-29 (schizophrenia spectrum) or F31 (bipolar affective disorder)
- Current use of antipsychotic medication (first- or second generation) or lithium
- Body Mass Index \> or = 27 kg/m\^2
You likely can't join if
- Psychiatric condition:
- Inability to provide informed consent\
- Acute psychiatric crisis\
- Significant cognitive impairment\ \ These criteria will be evaluated and confirmed by the participant's primary mental health care provider before...
- GLP-1 receptor agonists
- Antihypertensive medication
See the full eligibility criteria
- Diagnosis of F20-29 (schizophrenia spectrum) or F31 (bipolar affective disorder)
- Current use of antipsychotic medication (first- or second generation) or lithium
- Body Mass Index \> or = 27 kg/m\^2
- Psychiatric condition:
- Inability to provide informed consent\
- Acute psychiatric crisis\
- Significant cognitive impairment\ \ These criteria will be evaluated and confirmed by the participant's primary mental health care provider before enrollment Medication initiated during the intervention period:
- GLP-1 receptor agonists
- Antihypertensive medication
- Antidiabetic medication
- Lipid-lowering medication Alcohol consumption: -More than 14 units per week (men) or more than 7 units per week (women) Somatic conditions:
- Type 1 diabetes
- Established cardiovascular disease
- Body Mass Index (BMI) \<27 kg/m²
- Pregnancy
- Inability to perform physical exercise Somatic risk findings at baseline:
- HbA1c \>57 mmol/mol (7.4%)
- LDL cholesterol \>5.0 mmol/L
- Blood pressure \>180/100 mmHg
- Active malignant disease
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.